5MC1
| Crystal Structure of Asp276Asn mutant of Human Prolidase with Mn ions and GlyPro ligand | Descriptor: | GLYCEROL, GLYCINE, MANGANESE (II) ION, ... | Authors: | Wilk, P, Mueller, U, Dobbek, H, Weiss, M.S. | Deposit date: | 2016-11-09 | Release date: | 2017-12-20 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.43 Å) | Cite: | Structural basis for prolidase deficiency disease mechanisms. FEBS J., 285, 2018
|
|
5MBZ
| Crystal Structure of Ser202Phe mutant of Human Prolidase with Mn ions and GlyPro ligand | Descriptor: | CHLORIDE ION, GLYCEROL, GLYCINE, ... | Authors: | Wilk, P, Mueller, U, Dobbek, H, Weiss, M.S. | Deposit date: | 2016-11-09 | Release date: | 2017-12-20 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.5 Å) | Cite: | Structural basis for prolidase deficiency disease mechanisms. FEBS J., 285, 2018
|
|
5MC5
| Crystal Structure of delGlu452 mutant of Human Prolidase with Mn ions and GlyPro ligand | Descriptor: | GLYCEROL, GLYCINE, HYDROXIDE ION, ... | Authors: | Wilk, P, Mueller, U, Dobbek, H, Weiss, M.S. | Deposit date: | 2016-11-09 | Release date: | 2017-12-20 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Structural basis for prolidase deficiency disease mechanisms. FEBS J., 285, 2018
|
|
5MC3
| Crystal Structure of Glu412Lys mutant of Human Prolidase with Mn ions and GlyPro ligand | Descriptor: | GLYCEROL, GLYCINE, HYDROXIDE ION, ... | Authors: | Wilk, P, Mueller, U, Dobbek, H, Weiss, M.S. | Deposit date: | 2016-11-09 | Release date: | 2017-12-20 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.52 Å) | Cite: | Structural basis for prolidase deficiency disease mechanisms. FEBS J., 285, 2018
|
|
5MC4
| Crystal Structure of Gly448Arg mutant of Human Prolidase with Mn ions and GlyPro ligand | Descriptor: | GLYCEROL, GLYCINE, HYDROXIDE ION, ... | Authors: | Wilk, P, Mueller, U, Dobbek, H, Weiss, M.S. | Deposit date: | 2016-11-09 | Release date: | 2017-12-20 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Structural basis for prolidase deficiency disease mechanisms. FEBS J., 285, 2018
|
|
5MC0
| Crystal Structure of delTyr231 mutant of Human Prolidase with Mn ions and GlyPro ligand | Descriptor: | CHLORIDE ION, GLYCEROL, GLYCINE, ... | Authors: | Wilk, P, Mueller, U, Dobbek, H, Weiss, M.S. | Deposit date: | 2016-11-09 | Release date: | 2017-12-20 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.56 Å) | Cite: | Structural basis for prolidase deficiency disease mechanisms. FEBS J., 285, 2018
|
|
5MC2
| Crystal Structure of Gly278Asp mutant of Human Prolidase with Mn ions and GlyPro ligand | Descriptor: | GLYCEROL, GLYCINE, MANGANESE (II) ION, ... | Authors: | Wilk, P, Mueller, U, Dobbek, H, Weiss, M.S. | Deposit date: | 2016-11-09 | Release date: | 2017-12-20 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Structural basis for prolidase deficiency disease mechanisms. FEBS J., 285, 2018
|
|
5NHG
| Crystal structure of the human dihydrolipoamide dehydrogenase | Descriptor: | 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, Dihydrolipoyl dehydrogenase, ... | Authors: | Szabo, E, Mizsei, R, Wilk, P, Zambo, Z, Torocsik, B, Weiss, M.S, Adam-Vizi, V, Ambrus, A. | Deposit date: | 2017-03-21 | Release date: | 2018-05-16 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (2.27 Å) | Cite: | Crystal structures of the disease-causing D444V mutant and the relevant wild type human dihydrolipoamide dehydrogenase. Free Radic. Biol. Med., 124, 2018
|
|
2JCW
| REDUCED BRIDGE-BROKEN YEAST CU/ZN SUPEROXIDE DISMUTASE ROOM TEMPERATURE (298K) STRUCTURE | Descriptor: | COPPER (I) ION, CU/ZN SUPEROXIDE DISMUTASE, ZINC ION | Authors: | Hart, P.J, Balbirnie, M.M, Ogihara, N.L, Nersissian, A.M, Weiss, M.S, Valentine, J.S, Eisenberg, D. | Deposit date: | 1998-12-21 | Release date: | 1999-06-08 | Last modified: | 2023-08-09 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | A structure-based mechanism for copper-zinc superoxide dismutase. Biochemistry, 38, 1999
|
|
8OGS
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry B08 | Descriptor: | Cyclic di-AMP synthase CdaA, MAGNESIUM ION, ethyl 1,3-dihydro-2H-pyrrolo[3,4-c]pyridine-2-carboxylate | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-20 | Release date: | 2024-03-27 | Method: | X-RAY DIFFRACTION (1.25 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry B08 To Be Published
|
|
8OHF
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F04 | Descriptor: | Cyclic di-AMP synthase CdaA, MAGNESIUM ION, N-[(4-bromo-3-methylphenyl)methyl]-2-(methylsulfonyl)ethan-1-amine | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.22 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F04 To Be Published
|
|
8OHB
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry E08 | Descriptor: | 5-(2-methoxyethyl)-1,3,4-oxadiazol-2-amine, Cyclic di-AMP synthase CdaA, MAGNESIUM ION | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.11 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry E08 To Be Published
|
|
8OHE
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F03 | Descriptor: | Cyclic di-AMP synthase CdaA, MAGNESIUM ION, N-(3-fluorophenyl)-2-(2-methoxyethoxy)acetamide | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.15 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F03 To Be Published
|
|
8OHL
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H09 | Descriptor: | (2~{R})-2-fluoranyl-2-(4-fluoranyl-1,2,4$l^{4}-triazacyclopenta-2,4-dien-1-yl)-1-phenyl-ethanone, Cyclic di-AMP synthase CdaA, MAGNESIUM ION | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.29 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H09 To Be Published
|
|
8OHC
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry E12 | Descriptor: | 6-azanyl-3-methyl-1,3-benzoxazol-2-one, Cyclic di-AMP synthase CdaA, MAGNESIUM ION | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.17 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry E12 To Be Published
|
|
8OHJ
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry G08 | Descriptor: | Cyclic di-AMP synthase CdaA, MAGNESIUM ION, N-ethyl-2-{[5-(propan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetamide | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.22 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry G08 To Be Published
|
|
8OHH
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry G05 | Descriptor: | Cyclic di-AMP synthase CdaA, MAGNESIUM ION, N-phenyl-N'-propan-2-ylurea | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.3 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry G05 To Be Published
|
|
8OGW
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry D02 | Descriptor: | Cyclic di-AMP synthase CdaA, MAGNESIUM ION, ~{N}-[5-azanyl-2,4-bis(fluoranyl)phenyl]propane-1-sulfonamide | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-20 | Release date: | 2024-03-27 | Method: | X-RAY DIFFRACTION (1.17 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry D02 To Be Published
|
|
8OHG
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F09 | Descriptor: | 4-pyridin-2-ylphenol, Cyclic di-AMP synthase CdaA, MAGNESIUM ION | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.25 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry F09 To Be Published
|
|
8OHK
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H01 | Descriptor: | Cyclic di-AMP synthase CdaA, MAGNESIUM ION, ~{N},~{N}-diethyl-2-(4-nitrophenoxy)ethanamine | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.26 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H01 To Be Published
|
|
8OHO
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H11 | Descriptor: | 1-cyclopentyl-3-[[(2~{S})-oxolan-2-yl]methyl]urea, Cyclic di-AMP synthase CdaA, MAGNESIUM ION, ... | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-21 | Release date: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.32 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry H11 To Be Published
|
|
8OGO
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry A12 | Descriptor: | 3-(propan-2-yl)-1,2,4-oxadiazol-5(4H)-one, Cyclic di-AMP synthase CdaA, MAGNESIUM ION | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-20 | Release date: | 2024-03-27 | Method: | X-RAY DIFFRACTION (1.21 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry A12 To Be Published
|
|
8OGV
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry C08 | Descriptor: | (3S)-3-hydroxy-2-methyl-2,3-dihydro-1H-isoindol-1-one, Cyclic di-AMP synthase CdaA, MAGNESIUM ION | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-20 | Release date: | 2024-03-27 | Method: | X-RAY DIFFRACTION (1.25 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry C08 To Be Published
|
|
8OH0
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry D08 | Descriptor: | 1-(2-ethylsulfonylethyl)-1,3,3-trimethyl-urea, Cyclic di-AMP synthase CdaA, MAGNESIUM ION | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-20 | Release date: | 2024-03-27 | Method: | X-RAY DIFFRACTION (1.27 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry D08 To Be Published
|
|
8OGU
| PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry C07 | Descriptor: | 3,4-dihydro-1~{H}-quinolin-2-one, Cyclic di-AMP synthase CdaA, MAGNESIUM ION | Authors: | Garbers, T.B, Neumann, P, Wollenhaupt, J, Weiss, M.S, Ficner, R. | Deposit date: | 2023-03-20 | Release date: | 2024-03-27 | Method: | X-RAY DIFFRACTION (1.41 Å) | Cite: | PanDDA analysis group deposition -- CdaA in complex with fragment F2X-Entry C07 To Be Published
|
|